| __timestamp | Supernus Pharmaceuticals, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 116287000 | 1162636000 |
| Thursday, January 1, 2015 | 136004000 | 1396725000 |
| Friday, January 1, 2016 | 203017000 | 1526100000 |
| Sunday, January 1, 2017 | 287023000 | 1619600000 |
| Monday, January 1, 2018 | 393541000 | 1429100000 |
| Tuesday, January 1, 2019 | 376095000 | 1331200000 |
| Wednesday, January 1, 2020 | 467938000 | 1375200000 |
| Friday, January 1, 2021 | 504714000 | 1563000000 |
| Saturday, January 1, 2022 | 580017000 | 1789600000 |
| Sunday, January 1, 2023 | 523742000 | 2070000000 |
Cracking the code
In the competitive landscape of biopharmaceuticals, United Therapeutics Corporation and Supernus Pharmaceuticals, Inc. have showcased distinct trajectories in gross profit performance from 2014 to 2023. United Therapeutics, a leader in the field, consistently outperformed its peer, with gross profits peaking at approximately $2.07 billion in 2023, marking a 78% increase from 2014. Meanwhile, Supernus Pharmaceuticals demonstrated steady growth, achieving a gross profit of around $524 million in 2023, a remarkable 350% rise since 2014.
This decade-long analysis highlights United Therapeutics' robust market position, maintaining an average gross profit nearly four times that of Supernus. However, Supernus' impressive growth rate underscores its potential to capture a larger market share. As the biopharmaceutical industry evolves, these companies' financial performances offer valuable insights into their strategic directions and market dynamics.
Sanofi vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Trends Compared: Zoetis Inc. vs United Therapeutics Corporation
Takeda Pharmaceutical Company Limited vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
United Therapeutics Corporation and Incyte Corporation: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing United Therapeutics Corporation and Amneal Pharmaceuticals, Inc.
Gross Profit Trends Compared: United Therapeutics Corporation vs Arrowhead Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? United Therapeutics Corporation or Veracyte, Inc.
Gross Profit Trends Compared: United Therapeutics Corporation vs MiMedx Group, Inc.
Key Insights on Gross Profit: United Therapeutics Corporation vs BioCryst Pharmaceuticals, Inc.
Incyte Corporation vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Alkermes plc and Supernus Pharmaceuticals, Inc.
MorphoSys AG vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown